E teze

Theses metadata

“Data exchange” service offers individual users metadata transfer in several different formats. Citation formats are offered for transfers in texts as for the transfer into internet pages. Citation formats include permanent links that guarantee access to cited sources. For use are commonly structured metadata schemes : Dublin Core xml and ETUB-MS xml, local adaptation of international ETD-MS scheme intended for use in academic documents.

Export

Creator:	Conić, Irena 1979-
Title:	Klinički tok karcinoma jajnika u zavisnosti od patohistoloških i imunohistohemijskih karakteristika tumora : doktorska disertacija
Copyright date:	2014
Permanent link:	https://phaidrani.ni.ac.rs/detail_object/o:982?tab=0#mda
Full text preview:
Download link:
Select license:	Autorstvo-Nekomercijalno-Deliti pod istim uslovima 3.0 Srbija (CC BY-NC-SA 3.0)
License description:	Dozvoljavate umnožavanje, distribuciju i javno saopštavanje dela, i prerade, ako se navede ime autora na način odredjen od strane autora ili davaoca licence i ako se prerada distribuira pod istom ili sličnom licencom. Ova licenca ne dozvoljava komercijalnu upotrebu dela i prerada. Osnovni opis Licence: http://creativecommons.org/licenses/by-nc-sa/3.0/rs/deed.sr_LATN Sadržaj ugovora u celini: http://creativecommons.org/licenses/by-nc-sa/3.0/rs/legalcode.sr-Latn

Academic metadata

Theses Type:	PhD thesis
Academic Expertise :	Medicinske nauke
University:	Univerzitet u Nišu
Faculty:	Medicinski fakultet
Group:	Katedra za ginekologiju sa akušerstvom

Other Theses Metadata

Title translated:	CLINICAL COURSE OF OVARIAN CARCINOMA DEPENDING ON PATOHISTOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS
Publisher:	Niš : [I. Conić]
Format:	PDF/A (175 listova)
description:	Umnoženo za odbranu. Univerzitet u Nišu, Medicinski fakultet., 2014. Bibliografija: listovi 143-172. Beleška o autoru: list 175. Sažetak ; Summary.
Other responsibilities:	Stanojević, Zorica (mentor)
Other responsibilities:	Vrbić, Svetislav (član komisije)
Other responsibilities:	Janković-Veličković, Ljubinka (član komisije)
Other responsibilities:	Jovanović, Darjana (član komisije)
Other responsibilities:	Krstić, Miljan (član komisije)
Abstract:	Introduction: According to the frequency of malignant tumours in the world, ovarian carcinoma takes the eighth place; it is also the fifth most frequent tumour in women and the fourth cause of cancer death in women. In early discovering and treatment of ovarian carcinoma, before it expends out of the primary localisation, the five-year relative survival rate is 92%. Unfortunately, only 15% of all ovarian carcinomas are discovered in the early stage. It has been noticed that the survival rate is higher in women under the age of 65 than in the older ones and it varies depending on the morphological type of ovarian carcinoma, patient’s over-all health condition and the stage of the disease diffusion at the time of setting the diagnosis. The exact cause of ovarian carcinoma occurrence is still unknown, but many risk factors are related to the occurrence of this malignoma. The aim of this research was to analyze the clinical and pathological characteristics of ovarian carcinoma, as well as to determine Nanog, Sox2, Oct3/4, Sox4, CD44. CD117, Ezh2 and Stat3 expressions in paraffin sections of ovarian carcinoma and to compare the Nanog, Sox2, Oct3/4, Sox4, CD44, Ezh2 and Stat3 expressions with the clinical and pathological characteristics of ovarian carcinoma. Methods: During the research, the immunohistochemical method was applied. Paraffin sections of the tissue of ovarian carcinoma 5μm thick were used. Conclusion: Unfavourable clinical course of ovarian carcinoma was related to the positive Nanog, Sox2 and Oct3/4 expression, as well as with the absence or low expression of Sox4, CD117 and CD44, while the loss of Ezh2 and Stat3 expressions in ovarian carcinoma, indicated significantly longer survival.
Authors Key words:	Karcinom jajnika, Nanog, Sox2, Oct3/4, Sox4, CD44, CD117, Ezh2, Stat3
Authors Key words:	ovarian carcinoma, Nanog, Sox2, Oct3/4, Sox4, CD44. CD117, Ezh2, Stat3
Classification:	618
Language:	Serbian
Identifier:	1025133549
Type:	Elektronska teza

Abstract:

Introduction: According to the frequency of malignant tumours in the world, ovarian carcinoma takes the eighth place; it is also the fifth most frequent tumour in women and the fourth cause of cancer death in women. In early discovering and treatment of ovarian carcinoma, before it expends out of the primary localisation, the five-year relative survival rate is 92%. Unfortunately, only 15% of all ovarian carcinomas are discovered in the early stage. It has been noticed that the survival rate is higher in women under the age of 65 than in the older ones and it varies depending on the morphological type of ovarian carcinoma, patient’s over-all health condition and the stage of the disease diffusion at the time of setting the diagnosis. The exact cause of ovarian carcinoma occurrence is still unknown, but many risk factors are related to the occurrence of this malignoma. The aim of this research was to analyze the clinical and pathological characteristics of ovarian carcinoma, as well as to determine Nanog, Sox2, Oct3/4, Sox4, CD44. CD117, Ezh2 and Stat3 expressions in paraffin sections of ovarian carcinoma and to compare the Nanog, Sox2, Oct3/4, Sox4, CD44, Ezh2 and Stat3 expressions with the clinical and pathological characteristics of ovarian carcinoma. Methods: During the research, the immunohistochemical method was applied. Paraffin sections of the tissue of ovarian carcinoma 5μm thick were used. Conclusion: Unfavourable clinical course of ovarian carcinoma was related to the positive Nanog, Sox2 and Oct3/4 expression, as well as with the absence or low expression of Sox4, CD117 and CD44, while the loss of Ezh2 and Stat3 expressions in ovarian carcinoma, indicated significantly longer survival.